Given that YTHDC1 expression levels are markedly reduced in the synovial tissue of RA patients, YTHDC1 may also be explored as a potential biomarker for early diagnosis or monitoring disease activity. The gene discussed is YTHDC1; the disease is rheumatoid arthritis.